Collegium is a dynamic biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions.   

We were founded on the conviction that the hardest health challenges, those shaped by misconceptions and complexity, require bold approaches to improve patient care. For more than a decade, that conviction has driven us to redefine expectations in these categories. 

For more information, please visit the Company’s website at collegiumpharma.com or find us on LinkedIn.